MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

    E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: The aim of our project is to develop small molecular weight compounds (Morphomers™) which bind selectively to alpha-synuclein (aSyn) aggregates, in order to generate…
  • 2016 International Congress

    DTI in Parkinson’s disease: Asymmetric progression

    L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)

    Objective: To study the rate of change of brain region diffusion tensor imaging (DTI) parameters between the right and left sides in PD patients using…
  • 2016 International Congress

    Critical path for Parkinson’s II: Global regulatory agencies support the use of dopamine transporter neuroimaging as an enrichment biomarker to enable clinical trials in early Parkinson’s disease

    D.T. Stephenson, S. Arneric, D. Babcock, P. Cole, T. Comery, M.F. Gordon, D. Grosset, D. Hill, S.Z. Imam, C.R. Jarecke, V. Kern, D. Matthews, R. Meibach, K. Romero, A. Roach, D. Russell, J. Seibyl, P. Sherwin, B.A. Sieber, L. Slicker, C. Sur, K. Marek (Tucson, AZ, USA)

    Objective: This presentation focuses on neuroimaging of the Dopamine Transporter as an enrichment biomarker in clinical trials of Parkinson's disease (PD). Background: The Critical Path…
  • 2016 International Congress

    A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease

    J. Wang, Z. Mosher, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

    Objective: To study the dynamic changes of the olfactory cortex function in the early-stage Parkinson's disease (PD) using functional magnetic resonance imaging (fMRI). Background: Olfactory…
  • 2016 International Congress

    The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

    S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)

    Objective: The objective of this study was to identify metabolic group differences between Idiopatic Parkinson's disease patients with dementia (PDD) and without dementia (PD), by…
  • 2016 International Congress

    Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis

    G. Rizzo, S. Arcuti, M. Copetti, M. Alessandria, R. Savica, A. Fontana, R. Liguori, G. Logroscino (Bologna, Italy)

    Objective: To perform a systematic review of the studies on diagnostic accuracy in dementia with Lewy bodies (DLB) and to meta-analyse sensitivity, specificity and accuracy…
  • 2016 International Congress

    Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview

    R. Ando, C. Yamazaki, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, K. Nakashima, M. Nomoto, Safe Driving Study Group of Japan (Tohon, Japan)

    Objective: We investigated the vehicle driving situation, clinical signs and symptoms of PD patients to obtain the information for safe driving. Background: PD neurologists are…
  • 2016 International Congress

    Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia

    Y.P. Chang, Y.H. Yang, C.L. Lai, L.M. Liou (Kaohsiung, Taiwan)

    Objective: To observe whether visual hallucinations serve as a predictor of Parkinson's disease dementia. Background: Visual hallucinations (VH) is one of non-motor symptoms in Parkinson's…
  • 2016 International Congress

    Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment

    R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris (London, United Kingdom)

    Objective: To demonstrate quantifiable differences in cortical visual processing in patients with Parkinson's disease with no evidence of dementia, as compared to controls. Background: Visual…
  • 2016 International Congress

    Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study

    S. Heinzel, U. Suenkel, F.G. Metzger, E. Schaeffer, B. Roeben, R. Yilmaz, S. Lerche, K. Brockmann, A.K. von Thaler, I. Liepelt-Scarfone, G.W. Eschweiler, A.J. Fallgatter, W. Maetzler, D. Berg (Tübingen, Germany)

    Objective: To evaluate the impact of gender, age and hyposmia on the cognitive performance in memory, language, executive, and visuo-spatial functions to set the stage…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley